Join us:
January 10–12, 2022 in-personJanuary 17–19, 2022 virtually

Donna Cryer
President and CEO at Global Liver Institute


Donna R. Cryer, JDisFounder, President andChief Executive Officer of the Global LiverInstitute, the only patient-driven liver health nonprofit operating in the US and Europe. She haschanneled her personal experience as a patient with inflammatory bowel disease and a 25-yearliver transplant recipient into professional advocacy across a career in law, policy, consulting,public relations, clinical trial recruitment, and nonprofit management.For almost a decade Mrs. Cryer founded and led CryerHealth, a healthcare consulting firmproviding strategic counsel to top biopharmaceutical companies, patient advocacy organizations,and emerging technology firms on patient engagement in health information technology, drugdiscovery, and clinical decision making.Mrs. Cryer serves on the Boards of Directors ofthe Council of Medical Specialty Societies, theInnovation and Value Initiative (IVI), Sibley Memorial Hospital/Johns Hopkins Medicine,andtheExecutive Committee for the Clinical Trials Transformation Initiative.She is a frequent speaker on the topic of patient-centeredness and patient engagement inhealthcare transformation and created a unique model for advocacy that mobilizes patients,influences policy, andcoalesces clinicians to improve patient outcomes. Mrs. Cryerhas beenkeynote speaker or featured panelistat meetings and conferences including conducted byBIO,DIA,PhRMA, AHIP, National Quality Forum, mHealth Summit, DigitalHealth Summit, and theNational Academies of Medicine.Previously, Mrs. Cryer served on the Executive Committee of the People-Centered ResearchFoundation. She was appointed by the U.S. Government Accountability Office to serve as thepatient and consumerrepresentative on the Health Information Technology Policy Committee,the federal advisory body to the National Coordinator for HIT, and served asa patientrepresentative to the U.S. Food and Drug Administration,a member of the Stakeholder AdvisoryGroupto the NIH Learning Health System Research Collaboratory, the ABIM GastroenterologySpecialty Board, and on an American Society of Clinical Oncology Guidelines Committee.She has been named one of the Top Blacks in Healthcare by the Milken Institute at GWSchoolof Public Health and, one of the Top 10 Patients Who Make An Impact byHealth 2.0 and one of PharmaVoice’s 100 Most Inspiring People.Mrs. Cryer received an undergraduate degree from Harvard/Radcliffe Colleges and a JurisDoctoratefrom the Georgetown University Law Center.

Agenda Sessions

  • Advancing patient-centered value frameworks for novel therapeutics in rare disease

    On Demand

Speakers at this event